Scion Asset Management 13F Holdings and Investments

Scion Asset Management is a well-established investment firm that has been making waves in the financial world. It's a subsidiary of BlackRock, one of the largest asset managers globally.

In its 13F filings, Scion Asset Management reveals its significant investments in various sectors, including technology and consumer staples. The firm's investment strategy focuses on identifying undervalued companies with strong growth potential.

One notable investment is in Alphabet Inc., the parent company of Google, which Scion Asset Management has been steadily increasing its stake in.

Scion Asset Management's portfolio is a closely watched space, particularly given Michael Burry's impressive track record. He has a well-diversified investment approach, reflected in his current portfolio.

Michael Burry's top holdings include HCA Healthcare Inc, Citigroup Inc, Oracle Corp, Advance Auto Parts Inc, and Alphabet Inc - Ordinary Shares - Class A. These companies demonstrate Burry's confidence in the healthcare sector's resilience and growth potential, as well as his bet on the financial industry's stability and value-oriented banking stocks.

Burry's investment strategy favors strong companies capable of weathering economic uncertainties while offering solid long-term growth prospects. His top five stock holdings provide insight into his approach, which prioritizes established players in their respective industries.

Here are Scion Asset Management's top holdings, based on the September 2024 quarterly 13F filing:

Michael Burry's Scion Asset Management, LLC has some notable holdings that give us insight into his investment strategy. He has a well-diversified approach, with a focus on strong companies that can weather economic uncertainties.

One of his top investments is HCA Healthcare Inc, which reflects his confidence in the healthcare sector's resilience and growth potential. He also has a significant position in Alphabet Inc - Ordinary Shares - Class A, suggesting a strategic play on continued digital innovation and market leadership in online advertising, search, and cloud services.

Burry's portfolio also includes Oracle Corp, indicating an inclination towards established software and cloud service providers with robust enterprise client bases. He has a stake in Advance Auto Parts Inc, targeting the automotive parts sector, which could benefit from trends such as the increasing age of vehicles on the road.

Citigroup Inc represents his bet on the financial industry's stability and value-oriented banking stocks. This investment strategy favors strong companies with solid long-term growth prospects.

Michael Burry's portfolio is a treasure trove of insights into his investment strategy. He holds 8 positions in his portfolio as reported in the September 2024 quarterly 13F filing.

Scion Asset Management, the company behind Burry's portfolio, has a diverse range of holdings. These include JD.com, Alibaba Group Holding, and Baidu, which make up a significant portion of the portfolio.

Here are some key statistics about Burry's top holdings:

Burry's portfolio also includes positions in Shift4 Payments, Molina Healthcare, and Olaplex Holdings, among others. These holdings demonstrate his confidence in the growth potential of various industries, including healthcare and technology.

Scion Asset Management holds 8 positions in its portfolio as reported in the September 2024 quarterly 13F filing.

The company with the largest portfolio weight is Jd.com Spon Ads Cl A (JD), making up 30.8% of the portfolio.

The total value of Scion Asset Management's portfolio is $40M for Jd.com Spon Ads Cl A (JD) alone.

The portfolio weight of Alibaba Group Hldg Sponsored Ads (BABA) is 30.2%, making it the second largest holding.

Alibaba Group Hldg Sponsored Ads (BABA) is valued at $39M.

Scion Asset Management has increased its share count of Jd.com Spon Ads Cl A (JD) by 300% since the last filing.

The share price of Jd.com Spon Ads Cl A (JD) is $40.00.

Here is a list of Scion Asset Management's top 5 holdings:

Michael Burry's Investments are quite fascinating. He bought ~8,000 put options on Tesla, giving him exposure to an 800K notional share amount for $534M.

Burry's investment strategy is not limited to just one stock, as he has a diverse portfolio with various holdings. Some of his notable buys include Star Bulk Carriers (SBLK), Safe Bulkers (SB), Expedia Group (EXPE), and Charter Communications (CHTR).

Here are some of the key stocks he bought in Q2:

Burry's investment strategy is not just about buying stocks, as he also has a significant short position in Tesla via put options. He bought ~8,000 put options on Tesla, giving him exposure to an 800K notional share amount for $534M.

Michael Burry's Q2 stock buys are worth taking a closer look at. He invested in a variety of companies, including Star Bulk Carriers (SBLK) and Safe Bulkers (SB), both of which are in the shipping industry.

Scion Asset Management, the hedge fund run by Burry, bought stocks of these companies, among others, in Q2. Here are some of the notable buys:

These investments show that Burry is looking to diversify his portfolio and is willing to take on different types of companies.

Michael Burry's investments are always a topic of interest, and his recent short bet on Tesla is no exception. He bought around 8,000 put options on Tesla, giving him exposure to an 800K notional share amount for $534M.

Tesla trades at a larger market cap than the entire auto industry combined, yet it can't seem to sell cars at a profit. This is a red flag for many investors.

The chart for Tesla is one of the ugliest in Cathie Wood's family of businesses. This could be a sign of trouble ahead.

If you're considering joining Burry on this short, be sure to manage your risk accordingly. This could involve setting stop-losses or buying outright put positions.

Michael Burry's investments in the healthcare sector are worth exploring, especially given his background as a medical doctor. He has a competitive edge in this space due to his expertise in evaluating the potential efficacy of certain drugs.

Burry bought three new healthcare companies during Q1: Marinus Pharmaceuticals (MRNS), Aerpio Pharmaceuticals (ARPO), and ZymeWorks, Inc (ZYME).

As a medical doctor, Burry likely has a deep understanding of the medical field and can make informed investment decisions. This expertise gives him an edge over the average investor in the healthcare space.

Here are the three companies Burry invested in during Q1:

These investments reflect Burry's focus on healthcare companies with promising potential.